Yena Lee
Affiliations: | Psychiatry | University of Toronto, Toronto, ON, Canada |
Google:
"https://scholar.google.ca/citations?user=KRxwYA8AAAAJ&hl=en"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Gill H, Gill B, Chen-Li D, et al. (2020) The Emerging Role of Psilocybin and MDMA in the Treatment of Mental Illness. Expert Review of Neurotherapeutics |
Lipsitz O, McIntyre RS, Rodrigues NB, et al. (2020) Intravenous ketamine for postmenopausal women with treatment-resistant depression: Results from the Canadian Rapid Treatment Center of Excellence. Journal of Psychiatric Research |
McIntyre RS, Carvalho IP, Lui LMW, et al. (2020) The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis. Journal of Affective Disorders. 276: 576-584 |
Rodrigues NB, McIntyre RS, Lipsitz O, et al. (2020) Changes in symptoms of anhedonia in adults with major depressive or bipolar disorder receiving IV ketamine: Results from the Canadian Rapid Treatment Center of Excellence. Journal of Affective Disorders. 276: 570-575 |
Gill H, Perez CD, Gill B, et al. (2020) The prevalence of suicidal behaviour in fibromyalgia patients. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 110078 |
McIntyre RS, Subramaniapillai M, Park C, et al. (2020) The THINC-it Tool for Cognitive Assessment and Measurement in Major Depressive Disorder: Sensitivity to Change. Frontiers in Psychiatry. 11: 546 |
McIntyre RS, Rodrigues NB, Lee Y, et al. (2020) The effectiveness of repeated intravenous ketamine on depressive symptoms, suicidal ideation and functional disability in adults with major depressive disorder and bipolar disorder: Results from the Canadian Rapid Treatment Center of Excellence. Journal of Affective Disorders. 274: 903-910 |
Yim SJ, Lui LMW, Lee Y, et al. (2020) The utility of smartphone-based, ecological momentary assessment for depressive symptoms. Journal of Affective Disorders. 274: 602-609 |
Lee Y, Ragguett RM, Mansur RB, et al. (2020) Corrigendum to "Applications of machine learning algorithms to predict therapeutic outcomes in depression: A meta-analysis and systematic review." J Affect Disord. 241 (2018) 519-532. Journal of Affective Disorders. 274: 1211-1215 |
Siegel AN, Rodrigues N, Nasri F, et al. (2020) Novel therapeutic targets in mood disorders: Pentoxifylline (PTX) as a candidate treatment. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 110032 |